THYROCARE TECHNOLOGIES
Back to Cashflow Statement
|
THYROCARE TECHNOLOGIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-170 Cr | ₹-130 Cr | ₹-85 Cr | ₹-86 Cr | ₹-89 Cr |
What is the latest Cash Flow from Financing Activities ratio of THYROCARE TECHNOLOGIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-170 Cr |
| Mar2025 | ₹-130 Cr |
| Mar2024 | ₹-85 Cr |
| Mar2023 | ₹-86 Cr |
| Mar2022 | ₹-89 Cr |
How is Cash Flow from Financing Activities of THYROCARE TECHNOLOGIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-170 Cr | Negative | |
| Mar2025 | ₹-130 Cr | Negative | |
| Mar2024 | ₹-85 Cr | Negative | |
| Mar2023 | ₹-86 Cr | Negative | |
| Mar2022 | ₹-89 Cr | - | |
Compare Cash Flow from Financing Activities of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹8,466.3 Cr | -2.3% | 3.1% | 65.2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹127,019.0 Cr | 2.5% | 6.4% | 22.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹108,987.0 Cr | -1.8% | 14.6% | -11.2% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹73,389.5 Cr | 2.5% | 0.3% | 23.3% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹40,897.9 Cr | 1.7% | 4.7% | 32.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,887.5 Cr | 2.2% | 1.6% | -7.9% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -2.3% |
3.1% |
65.2% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses